What is the DSM-5 diagnostic criteria for adult ADHD?
The DSM-5 defines adult ADHD by persistent symptoms in two domains, with onset before age 12 and impairment in multiple settings:
- Inattention: Five or more symptoms persisting for at least six months — careless mistakes, difficulty sustaining attention, not listening when spoken to, failure to finish tasks, difficulty organizing, avoidance of sustained mental effort, losing items, distractibility, forgetfulness.
- Hyperactivity-impulsivity: Five or more symptoms — fidgeting, leaving seat, restlessness, difficulty engaging quietly, feeling driven by a motor, excessive talking, blurting answers, difficulty waiting turn, interrupting.
- Onset before age 12: Several symptoms must have been present before age 12, documented by self-report, collateral information, or school records.
- Cross-setting impairment: Symptoms must occur in two or more settings — work, home, school, social — and produce clinically significant functional impairment.
- Differential diagnosis: Symptoms are not better explained by another mental disorder. Substance-induced attention problems, mood disorders, anxiety disorders, and trauma are systematically ruled out before an ADHD diagnosis is made.
Diagnosis at Ascend uses a structured clinical interview, validated rating scales (ASRS-v1.1, CAARS), collateral history, and review of school or work records when available.
How is ADHD treated without stimulants?
FDA-approved non-stimulant medications for ADHD have demonstrated efficacy in randomized controlled trials and carry no abuse potential:
- Atomoxetine (Strattera): Selective norepinephrine reuptake inhibitor. FDA-approved for adult ADHD. Reaches full efficacy after four to six weeks. No controlled substance scheduling.
- Viloxazine (Qelbree): Serotonin-norepinephrine modulator. FDA-approved for adult ADHD in 2022. Onset of action within one to two weeks.
- Bupropion (Wellbutrin): Norepinephrine-dopamine reuptake inhibitor. Used off-label for adult ADHD, particularly when depression co-occurs. No abuse potential.
- Guanfacine (Intuniv) and clonidine (Kapvay): Alpha-2 adrenergic agonists. FDA-approved for ADHD in children; used off-label in adults, often as adjuncts for hyperarousal, sleep, and emotional regulation.
Pharmacotherapy is combined with CBT for ADHD, which addresses executive function deficits, time management, organization, and emotional regulation. The combination of medication and CBT produces larger effect sizes than either treatment alone.
Questions About How is ADHD treated?
Call our 24/7 admissions line or verify your insurance online.
Why are stimulant medications often avoided in SUD?
Methylphenidate and mixed amphetamine salts are Schedule II controlled substances carrying FDA black-box warnings for abuse and dependence. Several clinical realities make non-stimulant pharmacotherapy the standard for SUD populations:
- Diversion and abuse risk: Stimulant medications have established street value and documented misuse. Patients in early recovery face heightened cue exposure and craving when handling controlled substances.
- Cross-tolerance with cocaine and methamphetamine: The neuropharmacology of prescription stimulants overlaps with illicit stimulants, particularly for patients with stimulant use disorder history.
- Therapeutic equipoise: Non-stimulant medications produce comparable symptom reduction in many patients, especially when paired with CBT, without the abuse risk profile.
- Clinical guidelines: ASAM and APA practice guidelines recommend non-stimulant first-line pharmacotherapy for ADHD in patients with active or recent substance use disorders.
Stimulant medication can be appropriate in select cases after sustained recovery, with documented clinical justification, controlled dispensing arrangements, urine monitoring, and collateral involvement. The decision is individualized and made by Dr. Bishop in coordination with the treatment team.
“Adult ADHD is real, treatable, and seriously under-diagnosed — but stimulant prescribing in someone with active substance use is a setup for relapse. Non-stimulant medication plus CBT for ADHD gives patients durable symptom control without putting their recovery at risk.”
How does CBT for ADHD work?
CBT for adult ADHD is a structured, skills-based therapy targeting the executive function deficits that medication alone does not resolve:
- Time management and planning: Use of external systems — written planners, time-blocking, calendar reminders, structured weekly reviews — to compensate for working memory and prospective memory deficits.
- Organization and clutter management: Behavioral protocols for managing paper, digital files, physical environment, and incoming tasks. Reduces the cognitive load that worsens ADHD symptoms.
- Task initiation and procrastination: Behavioral activation strategies, task decomposition, and antecedent-behavior-consequence analysis applied to chronic procrastination patterns.
- Cognitive restructuring: Identifying and challenging maladaptive beliefs — perfectionism, all-or-nothing thinking, catastrophizing — that develop as a result of years of ADHD-related underachievement.
- Emotional regulation: DBT-informed skills for managing the rejection sensitivity, frustration intolerance, and mood reactivity common in adult ADHD.
CBT for ADHD is delivered individually and in skills groups at Ascend, integrated with the addiction treatment curriculum and coordinated with medication management.